Výsledky vyhledávání - "Céline Vidaillac"

Akademický článek

Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Autor: Thu-Minh Nguyen, Thu-Hue Ngo, Anh-Quan Truong, Dinh-Hoa Vu, Dinh-Chi Le, Ngan-Binh Vu, Tuyet-Nga Can, Hoang-Anh Nguyen, Thu-Phuong Phan, Françoise Van Bambeke, Céline Vidaillac, Quy-Chau Ngo

Publikováno v: Pharmaceutics, Vol 13, Iss 4, p 456 (2021)

Background: Ceftazidime and imipenem have been increasingly used to treat Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) due to their extended-spectrum covering Pseudomonas aeruginosa. This study aims to describe the population

Externí odkaz: https://doaj.org/article/62f45f79a19248eca91ec406c5ebc259

Zobrazit plný text záznamu

In Vitro Synergy of Colistin Combinations against Colistin-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates

Autor: Raphaël E. Duval, Lothaire Benichou, Céline Vidaillac

Publikováno v: Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2012, 56 (9), pp.4856-4861. ⟨10.1128/AAC.05996-11⟩

Colistin resistance, although uncommon, is increasingly being reported among Gram-negative clinical pathogens, and an understanding of its impact on the activity of antimicrobials is now evolving. We evaluated the potential for synergy of colistin pl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2610123c3b908a2589aea171fc223514
https://doi.org/10.1128/aac.05996-11

Zobrazit plný text záznamu

Synthesis and Initial Results for MAO-B Inhibition by New N-Propargyl-3-pyrrol-1-ylindanamine Derivatives, Analogues of Rasagiline

Autor: Jean Guillon, Guillaume Hébert, Patrick Dallemagne, Jean-Michel Léger, Céline Vidaillac, Corinne Thé, Vincent Lisowski, Sylvain Rault, Jacques Demotes-Mainard, Christian Jarry

Publikováno v: Journal of Enzyme Inhibition and Medicinal Chemistry. 18:147-153

The syntthesis of new N-propargyl-3-pyrrol-1-ylindanamine derivatives, analogues of rasagiline, is described in ten steps starting from the corresponding arylaldehydes via the corresponding cis-3-pyrrol-1-ylindanamines. The cis-configuration of some

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::228549dac6cc94ad8a9590e55c9d2630
https://doi.org/10.1080/1475636032000069800

Zobrazit plný text záznamu

First Diels-Alder Cycloaddition ofN′-Oxazolyl-N,N-dimethylalkylamidines with Electron-Poor Dienophiles: Characterization of a Diastereoselective Pathway

Autor: Jean Guillon, Jean-Michel Léger, Stéphane Massip, Corinne Thé, Céline Vidaillac, Jean-Pierre Monti, Christian Jarry

Publikováno v: Synlett. :1249-1252

Diels-Alder cycloaddition of N'-oxazolyl-N,N-dimethylalkylamidines la,b with electron-poor dienophiles were performed, leading to new 2-phenoxymethyl-6-formyl-2,3-dihydro-5H-oxazolo[3,2-a]pyrimidines and 2-phenoxymethyl-6-nitro-2,3-dihydro-5H-oxazolo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::72316dad0e6812d14ca54747536358c5
https://doi.org/10.1055/s-2002-32954

Zobrazit plný text záznamu

Macrolides and staphylococcal biofilms

Autor: Jorge, Parra-Ruiz, Céline, Vidaillac, Michael J, Rybak

Publikováno v: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia. 25(1)

Medical device-associated infections represent a growing problem with limited or no therapeutic options beyond implant removal. Bacterial biofilm is the major and the final determinant of the poor prognosis of these difficult-to-treat infections. Due

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9253669b9fcbc6846ee20fab1c6bb4aa
https://pubmed.ncbi.nlm.nih.gov/22488536

Zobrazit plný text záznamu

Synthesis of new 4-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]quinoxaline and 5-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]thieno[3,2-e]pyrazine derivatives, as potential bacterial multidrug resistance pump inhibitors

Autor: Daniel-Henri Caignard, Patrick Dallemagne, Stéphane Larrouture, Christian Jarry, Jean Guillon, Claudine Quentin, Annie Lagardère, Céline Vidaillac, Stéphane Moreau, Corinne Arpin

Publikováno v: Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry, Informa Healthcare, 2007, 22 (5), pp.620-31

The synthesis of new 4-[2-(alkylamino)ethylthio]pyrrolo[1,2-a]quinoxaline derivatives la-1 is described in five or six steps starting from various substituted nitroanilines 2a-e. The bioisostere 5-[2-(alkylamino)ethylthio]pyrrolo[1,2- a]thieno[3,2-e]

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56d6130443c4ca17cc728d43dcf8da91
https://hal.archives-ouvertes.fr/hal-00319134

Zobrazit plný text záznamu

Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus

Autor: Daniel-Henri Caignard, Claudine Quentin, Stéphane Moreau, Corinne Arpin, Jean Guillon, Christian Jarry, Jean Grellet, Boubakar B. Ba, Isabelle Forfar-Bares, Céline Vidaillac

Publikováno v: Antimicrobial agents and chemotherapy. 51(3)

A series of 11 pyrrolo[1,2- a ]quinoxaline derivatives, 1a to 1k, sharing structural analogies with omeprazole, a eukaryotic efflux pump inhibitor (EPI) used as an antiulcer agent, was synthesized. Their inhibitory effect was evaluated using Staphylo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66fff3d3def9758c782a47f7df6a2510
https://pubmed.ncbi.nlm.nih.gov/17101679

Zobrazit plný text záznamu

Activity of gatifloxacin in an in vitro pharmacokinetic-pharmacodynamic model against Staphylococcus aureus strains either susceptible to ciprofloxacin or exhibiting various levels and mechanisms of ciprofloxacin resistance

Autor: Boubakar B. Ba, Marie-Claude Saux, Claudine Quentin, Corinne Arpin, Céline Vidaillac, Arnaud Chausse

Publikováno v: Antimicrobial agents and chemotherapy. 50(6)

Gatifloxacin (GAT) is a new 8-methoxy fluoroquinolone with enhanced activity against gram-positive cocci. Its activity was studied in an in vitro pharmacokinetic-pharmacodynamic model against five Staphylococcus aureus strains, either susceptible to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44fd2637b95c8182a9551129a5ff111b
https://pubmed.ncbi.nlm.nih.gov/16723548

Zobrazit plný text záznamu

Akademický článek

Development of a Good Clinical Practice inspection checklist to assess clinical trial sites in Vietnam

Autor: H Rogier van Doorn, Guy E Thwaites, Evelyne Kestelyn, Quang Ngo Nguyen, Nam Vinh Nguyen, Dung Thi Phuong Nguyen, Celine Vidaillac, Phuong Thi Minh Trinh, Ha Thi Nhi Vo

Publikováno v: BMJ Open, Vol 11, Iss 7 (2021)

Background Assessing the capacity of a healthcare institution to conduct and manage clinical research studies is challenging, especially in developing countries where resources are limited. The objective of this study was to develop a practical and t

Externí odkaz: https://doaj.org/article/a44bb76d0e6c4f0bb684506d2cabfc4b

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání